Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review
One year after the prevalence of the novel coronavirus pandemic, some aspects of the physiopathology, treatment and progression of coronavirus 2019 disease (COVID-19) have remained unknown. Since no comprehensive study on the use of urological medications in patients with COVID-19 has been carried o...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-09-01
|
| Series: | Therapeutic Advances in Urology |
| Online Access: | https://doi.org/10.1177/17562872211046794 |
| _version_ | 1818440942648033280 |
|---|---|
| author | Mojtaba Shafiekhani Anahita Dehghani Mina Shahisavandi Seyed Ali Nabavizadeh Maryam Kabiri Amir Hossein Hassani Abdolreza Haghpanah |
| author_facet | Mojtaba Shafiekhani Anahita Dehghani Mina Shahisavandi Seyed Ali Nabavizadeh Maryam Kabiri Amir Hossein Hassani Abdolreza Haghpanah |
| author_sort | Mojtaba Shafiekhani |
| collection | DOAJ |
| description | One year after the prevalence of the novel coronavirus pandemic, some aspects of the physiopathology, treatment and progression of coronavirus 2019 disease (COVID-19) have remained unknown. Since no comprehensive study on the use of urological medications in patients with COVID-19 has been carried out, this narrative review aimed to focus on clinically important issues about the treatment of COVID-19 and urologic medications regarding efficacy, modifications, side effects and interactions in different urologic diseases. In this review, we provide information about the pharmacotherapeutic approach toward urologic medications in patients with COVID-19 infection. This study provides an overview of medications in benign prostatic hyperplasia, prostate cancer, impotence and sexual dysfunction, urolithiasis, kidney transplantation and hypertension as the most frequent diseases in which the patients are on long-term medications. Also, the effect of urologic drugs on the efficacy of vaccination is briefly discussed. |
| first_indexed | 2024-12-14T18:20:22Z |
| format | Article |
| id | doaj.art-0d00a57ef12f48d9bbfec87f12077438 |
| institution | Directory Open Access Journal |
| issn | 1756-2880 |
| language | English |
| last_indexed | 2024-12-14T18:20:22Z |
| publishDate | 2021-09-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Urology |
| spelling | doaj.art-0d00a57ef12f48d9bbfec87f120774382022-12-21T22:52:05ZengSAGE PublishingTherapeutic Advances in Urology1756-28802021-09-011310.1177/17562872211046794Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative reviewMojtaba ShafiekhaniAnahita DehghaniMina ShahisavandiSeyed Ali NabavizadehMaryam KabiriAmir Hossein HassaniAbdolreza HaghpanahOne year after the prevalence of the novel coronavirus pandemic, some aspects of the physiopathology, treatment and progression of coronavirus 2019 disease (COVID-19) have remained unknown. Since no comprehensive study on the use of urological medications in patients with COVID-19 has been carried out, this narrative review aimed to focus on clinically important issues about the treatment of COVID-19 and urologic medications regarding efficacy, modifications, side effects and interactions in different urologic diseases. In this review, we provide information about the pharmacotherapeutic approach toward urologic medications in patients with COVID-19 infection. This study provides an overview of medications in benign prostatic hyperplasia, prostate cancer, impotence and sexual dysfunction, urolithiasis, kidney transplantation and hypertension as the most frequent diseases in which the patients are on long-term medications. Also, the effect of urologic drugs on the efficacy of vaccination is briefly discussed.https://doi.org/10.1177/17562872211046794 |
| spellingShingle | Mojtaba Shafiekhani Anahita Dehghani Mina Shahisavandi Seyed Ali Nabavizadeh Maryam Kabiri Amir Hossein Hassani Abdolreza Haghpanah Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review Therapeutic Advances in Urology |
| title | Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review |
| title_full | Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review |
| title_fullStr | Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review |
| title_full_unstemmed | Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review |
| title_short | Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review |
| title_sort | pharmacotherapeutic approach toward urological medications and vaccination during covid 19 a narrative review |
| url | https://doi.org/10.1177/17562872211046794 |
| work_keys_str_mv | AT mojtabashafiekhani pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview AT anahitadehghani pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview AT minashahisavandi pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview AT seyedalinabavizadeh pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview AT maryamkabiri pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview AT amirhosseinhassani pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview AT abdolrezahaghpanah pharmacotherapeuticapproachtowardurologicalmedicationsandvaccinationduringcovid19anarrativereview |